US President's discretionary funding request includes new research agency

12 April 2021
biden_big

The US White House on Friday sent to Congress President Joe Biden’s discretionary funding request for the fiscal year 2022.

President Biden proposed huge increases for many federal research agencies as part of a $118 billion boost in domestic spending.

As Joe Biden's first budget request to Congress as President, it offers a look at his priorities on healthcare and education, with increases in discretionary - or optional spending - across the board. A proposal detailing mandatory spending requests - which includes Medicaid and Medicare - will come later, said White House officials.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical